biotech
biotech Articles
Investors in the biotech and biohealth space generally are taking on much more risk than in the likes of most Dow and S&P 500 stocks. That means they will demand more potential upside for that...
Published:
Last Updated:
The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Published:
Last Updated:
CytRx absolutely crumbled in Tuesday’s session after the company released less than favorable late-stage results.
Published:
Last Updated:
Shire made waves Tuesday morning following a key FDA approval of its eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
Published:
Last Updated:
Protagonist Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline potential at current levels.
Published:
Last Updated:
Audentes Therapeutics expects to price its 5 million shares in the range of $14 to $16, for an initial public offering valued up to $92 million.
Published:
Last Updated:
Juno Therapeutics saw its shares sink on Friday after the U.S. Food and Drug Administration levied a clinical hold on its leukemia treatment.
Published:
Last Updated:
Juno Therapeutics saw its shares sink early on Friday after the U.S. Food and Drug Administration (FDA) levied a clinical hold on its leukemia treatment.
Published:
Last Updated:
Shares of Eleven Biotherapeutics saw a handy gain early on Friday after the company announced that its Investigational New Drug application for EBI-031 has become effective.
Published:
Last Updated:
PTC Therapeutics made waves on Thursday following a development in its nonsense mutation Duchenne muscular dystrophy (nmDMD) treatment.
Published:
Last Updated:
Flexion Therapeutics has announced that three new executives have joined the company in key marketing, medical affairs and market access roles.
Published:
Last Updated:
Insys Therapeutics announced that the FDA has approved its dronabinol oral solution, Syndros, for use in treating anorexia associated with weight loss in patients with AIDS.
Published:
Last Updated:
Array BioPharma Inc. (NASDAQ: ARRY) is watching its shares make a handy gain on Friday after making a key U.S. Food and Drug Administration (FDA) submission. The company announced the submission of a...
Published:
Last Updated:
Lipocine Inc. (NASDAQ: LPCN) is watching its shares get cut in half in Wednesday’s session after receiving a letter from the U.S. Food and Drug Administration (FDA). The company announced that it...
Published:
Last Updated: